Silicon Valley-based ophthalmic device company OptiMedica Corp has closed a $35m growth round of financing, with participation from all of the company’s existing venture backers, including Kleiner Perkins Caufield & Byers, Alloy Ventures, DAG Ventures, BlackRock Private Equity Partners and Bio*One Capital.
Proceeds will be used to continue the global commercialisation of the company’s Catalys Precision Laser System for cataract surgery, support the development of system enhancements, and fuel a next-generation portfolio of additional products, it said.
Since its international launch in November 2011 and its US launch in February 2012, the system has been installed at ophthalmic practices in ten countries and used to perform more than 6,000 laser cataract procedures worldwide.
“The rapid worldwide adoption of Catalys is not only a direct result of the system’s unparalleled performance but also of the amazing talent and unique Silicon Valley culture that you’ll find at OptiMedica,” said Brook Byers, partner, Kleiner Perkins Caufield & Byers, and chairman of the board, OptiMedica. “This is a company with a proven track record of delivering innovation that transforms existing standards of care. We are very enthusiastic about OptiMedica’s long-term prospects to lead the field of cataract surgery and continue to drive better results for cataract surgeons and their patients.”
Copyright © 2012 AltAssets